APO Research
Talk to an analyst

APO RESEARCH · REPORT

RFID for Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global RFID for Pharmaceutical Market Outlook and Growth Opportunities 2026

5 March 2026192 pages

Choose your research edition.

Industry ResearchRFID for Pharmaceutical Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal RFID for Pharmaceutical Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal RFID for Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RFID for Pharmaceutical Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal RFID for Pharmaceutical Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global RFID for Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for RFID for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RFID for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RFID for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the RFID for Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the RFID for Pharmaceutical market include Terso Solutions, iGPS, Dipole, GAO Group, Turck, Avery Dennison, Aucxis, Murata Manufacturing and BIXOLON, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global RFID for Pharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RFID for Pharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RFID for Pharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global RFID for Pharmaceutical market.

RFID for Pharmaceutical Segment by Company

Terso Solutions

iGPS

Dipole

GAO Group

Turck

Avery Dennison

Aucxis

Murata Manufacturing

BIXOLON

Bionix Technologies

Tageos

Zebra Technologies

Checkpoint Systems (CCL Industries)

SML

RFID for Pharmaceutical Segment by Type

Tag

Printer

Others

RFID for Pharmaceutical Segment by Application

Inventory Management

Logistics Tracking

Others

RFID for Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global RFID for Pharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the RFID for Pharmaceutical key companies, revenue, market share, and recent developments.

3. To split the RFID for Pharmaceutical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions RFID for Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify RFID for Pharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze RFID for Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RFID for Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RFID for Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RFID for Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RFID for Pharmaceutical industry.

Chapter 3: Detailed analysis of RFID for Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of RFID for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of RFID for Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. RFID for Pharmaceutical Industry Trends Table 2. RFID for Pharmaceutical Industry Drivers Table 3. RFID for Pharmaceutical Industry Opportunities and Challenges Table 4. RFID for Pharmaceutical Industry Restraints Table 5. Global RFID for Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global RFID for Pharmaceutical Revenue Share by Company (2021-2026) Table 7. Global RFID for Pharmaceutical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global RFID for Pharmaceutical Key Company Manufacturing Base & Headquarters Table 9. Global RFID for Pharmaceutical Company, Product Type & Application Table 10. Global RFID for Pharmaceutical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global RFID for Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tag Table 15. Significant Companies of Printer Table 16. Significant Companies of Others Table 17. Global RFID for Pharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global RFID for Pharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global RFID for Pharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global RFID for Pharmaceutical Sales Value Share by Type (2021-2026) Table 21. Global RFID for Pharmaceutical Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Inventory Management Table 23. Significant Companies of Logistics Tracking Table 24. Significant Companies of Others Table 25. Global RFID for Pharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global RFID for Pharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global RFID for Pharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global RFID for Pharmaceutical Sales Value Share by Application (2021-2026) Table 29. Global RFID for Pharmaceutical Sales Value Share by Application (2027-2032) Table 30. Global RFID for Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global RFID for Pharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global RFID for Pharmaceutical Sales Value Share by Region (2021-2026) Table 33. Global RFID for Pharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global RFID for Pharmaceutical Sales Value Share by Region (2027-2032) Table 35. Global RFID for Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global RFID for Pharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global RFID for Pharmaceutical Sales Value Market Share by Country (2021-2026) Table 38. Global RFID for Pharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global RFID for Pharmaceutical Sales Value Market Share by Country (2027-2032) Table 40. Terso Solutions Company Information Table 41. Terso Solutions Business Overview Table 42. Terso Solutions RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Terso Solutions RFID for Pharmaceutical Product Portfolio Table 44. Terso Solutions Recent Development Table 45. iGPS Company Information Table 46. iGPS Business Overview Table 47. iGPS RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. iGPS RFID for Pharmaceutical Product Portfolio Table 49. iGPS Recent Development Table 50. Dipole Company Information Table 51. Dipole Business Overview Table 52. Dipole RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Dipole RFID for Pharmaceutical Product Portfolio Table 54. Dipole Recent Development Table 55. GAO Group Company Information Table 56. GAO Group Business Overview Table 57. GAO Group RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. GAO Group RFID for Pharmaceutical Product Portfolio Table 59. GAO Group Recent Development Table 60. Turck Company Information Table 61. Turck Business Overview Table 62. Turck RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Turck RFID for Pharmaceutical Product Portfolio Table 64. Turck Recent Development Table 65. Avery Dennison Company Information Table 66. Avery Dennison Business Overview Table 67. Avery Dennison RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Avery Dennison RFID for Pharmaceutical Product Portfolio Table 69. Avery Dennison Recent Development Table 70. Aucxis Company Information Table 71. Aucxis Business Overview Table 72. Aucxis RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Aucxis RFID for Pharmaceutical Product Portfolio Table 74. Aucxis Recent Development Table 75. Murata Manufacturing Company Information Table 76. Murata Manufacturing Business Overview Table 77. Murata Manufacturing RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Murata Manufacturing RFID for Pharmaceutical Product Portfolio Table 79. Murata Manufacturing Recent Development Table 80. BIXOLON Company Information Table 81. BIXOLON Business Overview Table 82. BIXOLON RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BIXOLON RFID for Pharmaceutical Product Portfolio Table 84. BIXOLON Recent Development Table 85. Bionix Technologies Company Information Table 86. Bionix Technologies Business Overview Table 87. Bionix Technologies RFID for Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bionix Technologies RFID for Pharmaceutical Product Portfolio Table 89. Bionix Technologies Recent Development Table 90. Tageos Company Information Table 91. Tageos Business Overview Table 92. Tageos RFID for Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Tageos RFID for Pharmaceutical Product Portfolio Table 94. Tageos Recent Development Table 95. Zebra Technologies Company Information Table 96. Zebra Technologies Business Overview Table 97. Zebra Technologies RFID for Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Zebra Technologies RFID for Pharmaceutical Product Portfolio Table 99. Zebra Technologies Recent Development Table 100. Checkpoint Systems (CCL Industries) Company Information Table 101. Checkpoint Systems (CCL Industries) Business Overview Table 102. Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Product Portfolio Table 104. Checkpoint Systems (CCL Industries) Recent Development Table 105. SML Company Information Table 106. SML Business Overview Table 107. SML RFID for Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. SML RFID for Pharmaceutical Product Portfolio Table 109. SML Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. RFID for Pharmaceutical Product Image Figure 2. Global RFID for Pharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RFID for Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global RFID for Pharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tag Image Figure 8. Printer Image Figure 9. Others Image Figure 10. Global RFID for Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global RFID for Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global RFID for Pharmaceutical Sales Value Share by Type (2021-2032) Figure 13. Inventory Management Image Figure 14. Logistics Tracking Image Figure 15. Others Image Figure 16. Global RFID for Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global RFID for Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global RFID for Pharmaceutical Sales Value Share by Application (2021-2032) Figure 19. Global RFID for Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global RFID for Pharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America RFID for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 22. North America RFID for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe RFID for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 24. Europe RFID for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific RFID for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific RFID for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America RFID for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 28. South America RFID for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa RFID for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa RFID for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt RFID for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Tag
  • Printer
  • Others
Applications
  • Inventory Management
  • Logistics Tracking
  • Others
Companies covered
  • Terso Solutions
  • iGPS
  • Dipole
  • GAO Group
  • Turck
  • Avery Dennison
  • Aucxis
  • Murata Manufacturing
  • BIXOLON
  • Bionix Technologies
  • Tageos
  • Zebra Technologies
  • Checkpoint Systems (CCL Industries)
  • SML

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global RFID for Pharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global RFID for Pharmaceutical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 RFID for Pharmaceutical Market Dynamics
  1. 2.1 RFID for Pharmaceutical Industry Trends
  2. 2.2 RFID for Pharmaceutical Industry Drivers
  3. 2.3 RFID for Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 RFID for Pharmaceutical Industry Restraints
3 RFID for Pharmaceutical Market by Company
  1. 3.1 Global RFID for Pharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global RFID for Pharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global RFID for Pharmaceutical Company Ranking (2024-2026)
  4. 3.4 Global RFID for Pharmaceutical Company Manufacturing Base and Headquarters
  5. 3.5 Global RFID for Pharmaceutical Company Product Type and Application
  6. 3.6 Global RFID for Pharmaceutical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global RFID for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 RFID for Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 RFID for Pharmaceutical Market by Type
  1. 4.1 RFID for Pharmaceutical Type Introduction
  2. 4.1.1 Tag
  3. 4.1.2 Printer
  4. 4.1.3 Others
  5. 4.2 Global RFID for Pharmaceutical Sales Value by Type
  6. 4.2.1 Global RFID for Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global RFID for Pharmaceutical Sales Value by Type (2021-2032)
  8. 4.2.3 Global RFID for Pharmaceutical Sales Value Share by Type (2021-2032)
5 RFID for Pharmaceutical Market by Application
  1. 5.1 RFID for Pharmaceutical Application Introduction
  2. 5.1.1 Inventory Management
  3. 5.1.2 Logistics Tracking
  4. 5.1.3 Others
  5. 5.2 Global RFID for Pharmaceutical Sales Value by Application
  6. 5.2.1 Global RFID for Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global RFID for Pharmaceutical Sales Value by Application (2021-2032)
  8. 5.2.3 Global RFID for Pharmaceutical Sales Value Share by Application (2021-2032)
6 RFID for Pharmaceutical Regional Value Analysis
  1. 6.1 Global RFID for Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RFID for Pharmaceutical Sales Value by Region (2021-2032)
  3. 6.2.1 Global RFID for Pharmaceutical Sales Value by Region: 2021-2026
  4. 6.2.2 Global RFID for Pharmaceutical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America RFID for Pharmaceutical Sales Value (2021-2032)
  7. 6.3.2 North America RFID for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe RFID for Pharmaceutical Sales Value (2021-2032)
  10. 6.4.2 Europe RFID for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific RFID for Pharmaceutical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific RFID for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America RFID for Pharmaceutical Sales Value (2021-2032)
  16. 6.6.2 South America RFID for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa RFID for Pharmaceutical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa RFID for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 RFID for Pharmaceutical Country-level Value Analysis
  1. 7.1 Global RFID for Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global RFID for Pharmaceutical Sales Value by Country (2021-2032)
  3. 7.2.1 Global RFID for Pharmaceutical Sales Value by Country (2021-2026)
  4. 7.2.2 Global RFID for Pharmaceutical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt RFID for Pharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt RFID for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt RFID for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Terso Solutions
  2. 8.1.1 Terso Solutions Company Information
  3. 8.1.2 Terso Solutions Business Overview
  4. 8.1.3 Terso Solutions RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Terso Solutions RFID for Pharmaceutical Product Portfolio
  6. 8.1.5 Terso Solutions Recent Developments
  7. 8.2 iGPS
  8. 8.2.1 iGPS Company Information
  9. 8.2.2 iGPS Business Overview
  10. 8.2.3 iGPS RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 iGPS RFID for Pharmaceutical Product Portfolio
  12. 8.2.5 iGPS Recent Developments
  13. 8.3 Dipole
  14. 8.3.1 Dipole Company Information
  15. 8.3.2 Dipole Business Overview
  16. 8.3.3 Dipole RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dipole RFID for Pharmaceutical Product Portfolio
  18. 8.3.5 Dipole Recent Developments
  19. 8.4 GAO Group
  20. 8.4.1 GAO Group Company Information
  21. 8.4.2 GAO Group Business Overview
  22. 8.4.3 GAO Group RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GAO Group RFID for Pharmaceutical Product Portfolio
  24. 8.4.5 GAO Group Recent Developments
  25. 8.5 Turck
  26. 8.5.1 Turck Company Information
  27. 8.5.2 Turck Business Overview
  28. 8.5.3 Turck RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Turck RFID for Pharmaceutical Product Portfolio
  30. 8.5.5 Turck Recent Developments
  31. 8.6 Avery Dennison
  32. 8.6.1 Avery Dennison Company Information
  33. 8.6.2 Avery Dennison Business Overview
  34. 8.6.3 Avery Dennison RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Avery Dennison RFID for Pharmaceutical Product Portfolio
  36. 8.6.5 Avery Dennison Recent Developments
  37. 8.7 Aucxis
  38. 8.7.1 Aucxis Company Information
  39. 8.7.2 Aucxis Business Overview
  40. 8.7.3 Aucxis RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aucxis RFID for Pharmaceutical Product Portfolio
  42. 8.7.5 Aucxis Recent Developments
  43. 8.8 Murata Manufacturing
  44. 8.8.1 Murata Manufacturing Company Information
  45. 8.8.2 Murata Manufacturing Business Overview
  46. 8.8.3 Murata Manufacturing RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Murata Manufacturing RFID for Pharmaceutical Product Portfolio
  48. 8.8.5 Murata Manufacturing Recent Developments
  49. 8.9 BIXOLON
  50. 8.9.1 BIXOLON Company Information
  51. 8.9.2 BIXOLON Business Overview
  52. 8.9.3 BIXOLON RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BIXOLON RFID for Pharmaceutical Product Portfolio
  54. 8.9.5 BIXOLON Recent Developments
  55. 8.10 Bionix Technologies
  56. 8.10.1 Bionix Technologies Company Information
  57. 8.10.2 Bionix Technologies Business Overview
  58. 8.10.3 Bionix Technologies RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bionix Technologies RFID for Pharmaceutical Product Portfolio
  60. 8.10.5 Bionix Technologies Recent Developments
  61. 8.11 Tageos
  62. 8.11.1 Tageos Company Information
  63. 8.11.2 Tageos Business Overview
  64. 8.11.3 Tageos RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tageos RFID for Pharmaceutical Product Portfolio
  66. 8.11.5 Tageos Recent Developments
  67. 8.12 Zebra Technologies
  68. 8.12.1 Zebra Technologies Company Information
  69. 8.12.2 Zebra Technologies Business Overview
  70. 8.12.3 Zebra Technologies RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zebra Technologies RFID for Pharmaceutical Product Portfolio
  72. 8.12.5 Zebra Technologies Recent Developments
  73. 8.13 Checkpoint Systems (CCL Industries)
  74. 8.13.1 Checkpoint Systems (CCL Industries) Company Information
  75. 8.13.2 Checkpoint Systems (CCL Industries) Business Overview
  76. 8.13.3 Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Product Portfolio
  78. 8.13.5 Checkpoint Systems (CCL Industries) Recent Developments
  79. 8.14 SML
  80. 8.14.1 SML Company Information
  81. 8.14.2 SML Business Overview
  82. 8.14.3 SML RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SML RFID for Pharmaceutical Product Portfolio
  84. 8.14.5 SML Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst